Literature summary for 3.4.21.69 extracted from

Hensley, L.E.; Stevens, E.L.; Yan, S.B.; Geisbert, J.B.; Macias, W.L.; Larsen, T.; Daddario-DiCaprio, K.M.; Cassell, G.H.; Jahrling, P.B.; Geisbert, T.W.
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever (2007), J. Infect. Dis., 196 Suppl 2, S390-S399.

Application

Application	Comment	Organism
medicine	the recombinant human activated protein C is useful for the postexposure treatment of Ebola hemorrhagic fever, clinical studies in rhesus monkeys, overview	Homo sapiens

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)